Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,641
Closed -$1.53M 1647
2025
Q1
$1.53M Buy
+36,641
New +$1.91M 0.1% 254
2024
Q3
Sell
-39,514
Closed -$2.52M 1332
2024
Q2
$2.52M Buy
+39,514
New +$2.97M 0.14% 188
2023
Q4
Sell
-21,983
Closed -$1.37M 1253
2023
Q3
$1.37M Buy
21,983
+4,038
+23% +$272K 0.13% 224
2023
Q2
$1.33M Buy
+17,945
New +$1.37M 0.14% 200
2022
Q2
Sell
-9,673
Closed -$622K 876
2022
Q1
$622K Buy
9,673
+6,698
+225% +$458K 0.14% 200
2021
Q4
$250K Sell
2,975
-3,897
-57% -$312K 0.06% 451
2021
Q3
$537K Buy
+6,872
New +$571K 0.1% 315
2021
Q1
Sell
-4,688
Closed -$251K 632
2020
Q4
$251K Buy
+4,688
New +$225K 0.11% 372

Other funds holding BRKR

Y-Intercept (HK)'s BRKR Position: Q2 2025 in Review

Y-Intercept (HK) sold out of Bruker (BRKR) in Q2 2025, closing a stake of 36,641 shares — an estimated $1.53M sold.

Y-Intercept (HK) first reported a position in BRKR in Q4 2020 and held it in 8 quarters. The position peaked at $2.52M in Q2 2024. 370 funds tracked by Wall St. Rank hold BRKR as of Q2 2025.

  • Y-Intercept (HK) reported no remaining Bruker position as of Q2 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 36,641 Bruker shares in Q2 2025, an estimated $1.53M.
  • Y-Intercept (HK) first reported a position in Bruker in Q4 2020 and held it in 8 quarters.
  • Y-Intercept (HK)'s Bruker position peaked at $2.52M in Q2 2024.
  • 370 funds tracked by Wall St. Rank held Bruker as of Q2 2025.

Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.